查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598371

男性荷尔蒙补充疗法市场：按适应症、产品类型、药用成分、分销管道、最终用户 - 全球预测 2025-2030

Testosterone Replacement Therapy Market by Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism), Product Type (Buccal Adhesive, Gel or Creams, Implants), Drug Active Ingredient, Distribution Channel, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年男性荷尔蒙补充疗法市值为5.1908亿美元，预计到2024年将达到5.5732亿美元，复合年增长率为7.85%，预计到2030年将达到8.8119亿美元。

雄性激素荷尔蒙补充疗法（TRT）是治疗方法。 TRT 的必要性在于其改善性功能、情绪、能量水平、肌肉和骨骼健康以及整体生活品质等因素的能力。 TRT 通常透过注射、贴片、凝胶或植入来应用，以满足各种患者的偏好。最终使用范围主要是专注于男性健康和荷尔蒙治疗的医院、诊所和健康中心。 TRT 市场成长的推动因素包括人们对睪固酮缺乏影响的认识不断提高、老年人口数量增加以及医疗保健提供方法的技术进步。经济状况和医疗保健支出趋势进一步影响成长。目前潜在的商机在于扩大远端医疗以扩大患者范围，以及开发非侵入性 TRT 产品以提高使用者依从性。公司可以根据遗传标记和患者的独特需求量身定制治疗方案，从而利用个人化医疗趋势。然而，这个市场面临着严格的法律规范、治疗潜在副作用以及高昂的治疗成本等挑战，这些挑战限制了准入并赶走了一些潜在消费者。创新的重点将是增强药物输送系统，以提高疗效和舒适度，同时减少副作用。将人工智慧融入患者诊断和治疗中可能会带来更准确、更有效率的治疗结果。由于研发投资的增加以及对新型治疗方法的需求不断增长，TRT市场的竞争逐渐加剧。公司应专注于策略伙伴关係和收购，以扩大其市场份额并利用药物开发的跨学科专业知识。对于致力于 TRT 行业永续成长和创新的相关人员来说，解决这些因素至关重要。

主要市场统计
基准年[2023] 51908万美元
预计年份 [2024] 55732万美元
预测年份 [2030] 88119万美元
复合年增长率（%） 7.85%

市场动态：快速发展的男性荷尔蒙补充疗法市场的关键市场洞察

供需的动态交互作用正在改变男性荷尔蒙补充疗法市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 睪酮缺乏症盛行率增加
    • 对睪固酮缺乏和勃起功能障碍治疗的认识不断增强
    • 非医疗应用的采用率很高，例如改善健美和性能力
  • 市场限制因素
    • 男性荷尔蒙补充疗法高成本
  • 市场机会
    • 加大新产品临床研发力度
    • 透过政府措施以及线上和线下药局提供药品
  • 市场挑战
    • 与男性荷尔蒙补充疗法相关的併发症

波特五力：引领男性荷尔蒙补充疗法市场的策略工具

波特的五力框架是了解男性荷尔蒙补充疗法市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对男性荷尔蒙补充疗法市场的影响

外部宏观环境因素在塑造雄性激素荷尔蒙补充疗法市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解男性荷尔蒙补充疗法市场的竞争格局

对男性荷尔蒙补充疗法市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV荷尔蒙补充疗法市场中的定位矩阵供应商绩效评估

FPNV 定位矩阵是评估雄性激素荷尔蒙补充疗法市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，为荷尔蒙补充疗法市场的成功指明道路

对于希望加强在全球市场的影响力的公司来说，对男性荷尔蒙补充疗法市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 睪酮缺乏症增加
      • 提高对治疗睪酮缺乏和勃起功能障碍的认识。
      • 健美和性能力增强等非医疗应用的采用率很高
    • 抑制因素
      • 男性荷尔蒙补充疗法的费用很高。
    • 机会
      • 加强新产品临床研发
      • 政府措施以及透过线上和线下药局提供药品
    • 任务
      • 与男性荷尔蒙补充疗法相关的併发症
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以适应症分類的男性荷尔蒙补充疗法市场

  • 自体免疫疾病
  • 遗传疾病
  • 性腺功能减退症
  • 生殖器手术

第七章男性荷尔蒙补充疗法市场：依产品类型

  • 颊黏膜黏剂
  • 凝胶或霜
  • 植入
  • 口服
  • 胃肠外的
  • 修补

第八章药物活性成分的男性荷尔蒙补充疗法市场

  • 甲基睪酮
  • 环丙酸睪酮
  • 庚酸睪酮

第九章男性荷尔蒙补充疗法市场：按分销管道

  • 医院药房
  • 网路和零售药局

第 10 章 男性荷尔蒙补充疗法市场：依最终使用者分类

  • 居家护理
  • 医院
  • 专科诊所

第十一章 北美和南美男性荷尔蒙补充疗法市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太男性荷尔蒙补充疗法市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的男性荷尔蒙补充疗法市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc
  • Acerus Pharmaceuticals Corp
  • Acrux Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.
  • Antares Pharma Inc.
  • Aytu BioPharma Inc.
  • Bausch Health Co. Inc
  • Bayer AG
  • Cipla Ltd.
  • Clarus Therapeutics Inc.,
  • Eli Lilly and Co.
  • Endo International Plc
  • Novartis AG,
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
Product Code: MRR-957C47F93749

The Testosterone Replacement Therapy Market was valued at USD 519.08 million in 2023, expected to reach USD 557.32 million in 2024, and is projected to grow at a CAGR of 7.85%, to USD 881.19 million by 2030.

Testosterone Replacement Therapy (TRT) is a medical treatment designed to increase testosterone levels in male individuals with low testosterone, addressing conditions like hypogonadism. The necessity of TRT is underscored by its ability to improve factors such as sexual function, mood, energy levels, muscle and bone health, and overall quality of life. It is commonly applied through injections, patches, gels, or implants, catering to diverse patient preferences. The end-use scope primarily encompasses hospitals, clinics, and health centers focusing on men's health and hormonal treatments. Market growth for TRT is propelled by factors including the rising awareness of testosterone deficiency's impact, increasing geriatric population, and technological advancements in healthcare delivery methods. Economic conditions and healthcare spending trends further influence growth. Current potential opportunities lie in expanding telemedicine for broader patient outreach and developing non-invasive TRT products to enhance user compliance. Companies can capitalize on personalized medicine trends by tailoring treatments based on genetic markers and patient-specific needs. However, the market faces challenges such as stringent regulatory frameworks, potential side effects of therapy, and high costs of treatment, limiting accessibility and deterring some potential consumers. Innovation could focus on enhancing drug delivery systems for better efficacy and comfort while reducing side effects. The incorporation of artificial intelligence in patient diagnosis and treatment might offer more precise and efficient outcomes. The nature of the TRT market is progressively competitive, driven by increasing investments in R&D and escalating demand for novel therapeutic approaches. Firms should emphasize strategic partnerships and acquisitions to broaden market presence and leverage cross-disciplinary expertise in drug development. Addressing these elements will be crucial for stakeholders aiming to drive sustainable growth and innovation in the TRT sector.

KEY MARKET STATISTICS
Base Year [2023] USD 519.08 million
Estimated Year [2024] USD 557.32 million
Forecast Year [2030] USD 881.19 million
CAGR (%) 7.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Testosterone Replacement Therapy Market

The Testosterone Replacement Therapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of testosterone deficiency
    • Rising awareness of treatment of testosterone deficiency and erectile dysfunction.
    • High adoption for non-medical uses such as body-building and enhancing sexual performance
  • Market Restraints
    • High cost of testosterone replacement therapy
  • Market Opportunities
    • Increased clinical research and development for novel products
    • Government initiatives and availability of drugs through online & offline pharmacies
  • Market Challenges
    • Complications associated with the testosterone replacement therapy

Porter's Five Forces: A Strategic Tool for Navigating the Testosterone Replacement Therapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Testosterone Replacement Therapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Testosterone Replacement Therapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Testosterone Replacement Therapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Testosterone Replacement Therapy Market

A detailed market share analysis in the Testosterone Replacement Therapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Testosterone Replacement Therapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Testosterone Replacement Therapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Testosterone Replacement Therapy Market

A strategic analysis of the Testosterone Replacement Therapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Testosterone Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc, Acerus Pharmaceuticals Corp, Acrux Ltd., Actiza Pharmaceutical Pvt. Ltd., Antares Pharma Inc., Aytu BioPharma Inc., Bausch Health Co. Inc, Bayer AG, Cipla Ltd., Clarus Therapeutics Inc.,, Eli Lilly and Co., Endo International Plc, Novartis AG,, Pfizer Inc., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Testosterone Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Autoimmune Conditions, Genetic Disorders, Hypogonadism, and Sex Organ Surgeries.
  • Based on Product Type, market is studied across Buccal Adhesive, Gel or Creams, Implants, Oral, Parenteral, and Patches.
  • Based on Drug Active Ingredient, market is studied across Methyltestosterone, Testosterone Cypionate, and Testosterone Enanthate.
  • Based on Distribution Channel, market is studied across Hospital Pharmacy and Online Pharmacy & Retail Pharmacy.
  • Based on End-Users, market is studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of testosterone deficiency
      • 5.1.1.2. Rising awareness of treatment of testosterone deficiency and erectile dysfunction.
      • 5.1.1.3. High adoption for non-medical uses such as body-building and enhancing sexual performance
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of testosterone replacement therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased clinical research and development for novel products
      • 5.1.3.2. Government initiatives and availability of drugs through online & offline pharmacies
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with the testosterone replacement therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Testosterone Replacement Therapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Autoimmune Conditions
  • 6.3. Genetic Disorders
  • 6.4. Hypogonadism
  • 6.5. Sex Organ Surgeries

7. Testosterone Replacement Therapy Market, by Product Type

  • 7.1. Introduction
  • 7.2. Buccal Adhesive
  • 7.3. Gel or Creams
  • 7.4. Implants
  • 7.5. Oral
  • 7.6. Parenteral
  • 7.7. Patches

8. Testosterone Replacement Therapy Market, by Drug Active Ingredient

  • 8.1. Introduction
  • 8.2. Methyltestosterone
  • 8.3. Testosterone Cypionate
  • 8.4. Testosterone Enanthate

9. Testosterone Replacement Therapy Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacy
  • 9.3. Online Pharmacy & Retail Pharmacy

10. Testosterone Replacement Therapy Market, by End-Users

  • 10.1. Introduction
  • 10.2. Homecare
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Americas Testosterone Replacement Therapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Testosterone Replacement Therapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Testosterone Replacement Therapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc
  • 2. Acerus Pharmaceuticals Corp
  • 3. Acrux Ltd.
  • 4. Actiza Pharmaceutical Pvt. Ltd.
  • 5. Antares Pharma Inc.
  • 6. Aytu BioPharma Inc.
  • 7. Bausch Health Co. Inc
  • 8. Bayer AG
  • 9. Cipla Ltd.
  • 10. Clarus Therapeutics Inc.,
  • 11. Eli Lilly and Co.
  • 12. Endo International Plc
  • 13. Novartis AG,
  • 14. Pfizer Inc.
  • 15. Sun Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TESTOSTERONE REPLACEMENT THERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY AUTOIMMUNE CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SEX ORGAN SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY BUCCAL ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY GEL OR CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY METHYLTESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE CYPIONATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TESTOSTERONE ENANTHATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY ONLINE PHARMACY & RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DRUG ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 239. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2023